Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival

BACKGROUND: Despite the popularity of immune checkpoint inhibitors (ICIs) in the treatment of advanced cancer, patients often develop gastrointestinal (GI) and non-GI immune-related adverse events (irAEs). The clinical characteristics and survival outcomes of GI-irAEs have not been fully elucidated...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Kentaro, Sawada, Tsunaki, Nakamura, Masanao, Yamamura, Takeshi, Maeda, Keiko, Ishikawa, Eri, Iida, Tadashi, Mizutani, Yasuyuki, Kakushima, Naomi, Ishikawa, Takuya, Furukawa, Kazuhiro, Ohno, Eizaburo, Honda, Takashi, Kawashima, Hiroki, Ishigami, Masatoshi, Furune, Satoshi, Hase, Tetsunari, Yokota, Kenji, Maeda, Osamu, Hashimoto, Naozumi, Akiyama, Masashi, Ando, Yuichi, Fujishiro, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613649/
https://www.ncbi.nlm.nih.gov/pubmed/34887637
http://dx.doi.org/10.3748/wjg.v27.i41.7190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613649/
https://www.ncbi.nlm.nih.gov/pubmed/34887637
http://dx.doi.org/10.3748/wjg.v27.i41.7190

Ejemplares similares